Schedule 13D ownership disclosure
Foghorn Therapeutics Inc
Security class unavailable · CUSIP: 344174107
Event date: 2020-10-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 26.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-281152
- Form type
- SC 13D
- Filer
- Flagship Ventures Fund V, L.P.
- CIK
- CIK 1627639
- Filed
- Oct 29, 2020
- Reporting period
- Oct 27, 2020
- Description
- Schedule 13D beneficial ownership